BIOMAT Database Logo BIOMAT Database Logo

Imidazo- and triazoloquinolones as antibacterial agents. Synthesis and structure-activity relationships. 1995

M Fujita, and H Egawa, and M Kataoka, and T Miyamoto, and J Nakano, and J Matsumoto
Exploratory Research Laboratories, Dainippon Pharmaceutical Company, Osaka, Japan.

4,5-Disubstituted 6-cyclopropyl-6,9-dihydro-9-oxo-1H-imidazo (30-32) and triazolo[4,5-f]quinoline-8-carboxylic acids (33-35) were synthesized starting from 5,6-diaminoquinolones 25. The imidazoquinolones 30-32 were equal or superior to the corresponding triazoloquinolone analogues 33-35 in in vitro antibacterial activity. As for the C-5 substituents, a fluorine atom was the most favorable of the three groups, H, F, and Cl. Among the compounds prepared, 4-(cyclic amino)-5-fluoro-imidazoquinolones 31 a-d showed potent and well-balanced antibacterial activity against both gram-positive and gram-negative bacteria. Structure-activity relationships for the C-4 substituents (cyclic amino groups) were also examined in detail.

UI MeSH Term Description Entries
D007093 Imidazoles Compounds containing 1,3-diazole, a five membered aromatic ring containing two nitrogen atoms separated by one of the carbons. Chemically reduced ones include IMIDAZOLINES and IMIDAZOLIDINES. Distinguish from 1,2-diazole (PYRAZOLES).
D008297 Male Males
D008815 Mice, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations, or by parent x offspring matings carried out with certain restrictions. All animals within an inbred strain trace back to a common ancestor in the twentieth generation. Inbred Mouse Strains,Inbred Strain of Mice,Inbred Strain of Mouse,Inbred Strains of Mice,Mouse, Inbred Strain,Inbred Mouse Strain,Mouse Inbred Strain,Mouse Inbred Strains,Mouse Strain, Inbred,Mouse Strains, Inbred,Strain, Inbred Mouse,Strains, Inbred Mouse
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D011552 Pseudomonas Infections Infections with bacteria of the genus PSEUDOMONAS. Infections, Pseudomonas,Pseudomonas aeruginosa Infection,Infection, Pseudomonas,Pseudomonas Infection,Pseudomonas aeruginosa Infections
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006094 Gram-Positive Bacteria Bacteria which retain the crystal violet stain when treated by Gram's method. Gram Positive Bacteria
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria

Related Publications

M Fujita, and H Egawa, and M Kataoka, and T Miyamoto, and J Nakano, and J Matsumoto
7-Azetidinylquinolones as antibacterial agents. Synthesis and structure-activity relationships.
April 1993, Journal of medicinal chemistry,
M Fujita, and H Egawa, and M Kataoka, and T Miyamoto, and J Nakano, and J Matsumoto
Synthesis and structure-activity relationships of new arylfluoronaphthyridine antibacterial agents.
November 1986, Journal of medicinal chemistry,
M Fujita, and H Egawa, and M Kataoka, and T Miyamoto, and J Nakano, and J Matsumoto
Synthesis and structure-activity relationships of novel arylfluoroquinolone antibacterial agents.
November 1985, Journal of medicinal chemistry,
M Fujita, and H Egawa, and M Kataoka, and T Miyamoto, and J Nakano, and J Matsumoto
Design, synthesis, and structure-activity relationships of benzophenone-based tetraamides as novel antibacterial agents.
August 2009, Journal of medicinal chemistry,
M Fujita, and H Egawa, and M Kataoka, and T Miyamoto, and J Nakano, and J Matsumoto
Phosphonopeptides as antibacterial agents: rationale, chemistry, and structure-activity relationships.
May 1979, Antimicrobial agents and chemotherapy,
M Fujita, and H Egawa, and M Kataoka, and T Miyamoto, and J Nakano, and J Matsumoto
Synthesis and structure-activity relationships of novel amino/nitro substituted 3-arylcoumarins as antibacterial agents.
January 2013, Molecules (Basel, Switzerland),
M Fujita, and H Egawa, and M Kataoka, and T Miyamoto, and J Nakano, and J Matsumoto
Phosphonopeptide antibacterial agents related to alafosfalin: design, synthesis, and structure-activity relationships.
December 1980, Antimicrobial agents and chemotherapy,
M Fujita, and H Egawa, and M Kataoka, and T Miyamoto, and J Nakano, and J Matsumoto
Novel amino-substituted 3-quinolinecarboxylic acid antibacterial agents: synthesis and structure-activity relationships.
September 1984, Journal of medicinal chemistry,
M Fujita, and H Egawa, and M Kataoka, and T Miyamoto, and J Nakano, and J Matsumoto
Structure-activity relationships of novel heteroaryl-acrylonitriles as cytotoxic and antibacterial agents.
September 2008, European journal of medicinal chemistry,
M Fujita, and H Egawa, and M Kataoka, and T Miyamoto, and J Nakano, and J Matsumoto
Fluoronaphthyridines and quinolones as antibacterial agents. 1. Synthesis and structure-activity relationships of new 1-substituted derivatives.
March 1989, Journal of medicinal chemistry,
Copied contents to your clipboard!